In tendinopathies, RegenKit A-PRP provides significant clinical benefits in up to 90% of patients with continuous improvement over time. 6,11,13,14,15
RegenKit BCT is CE Marked and is only available through authorized distributors. The Product has not been approved or cleared for marketing by the United States Food & Drug Administration.
The RegenKit BCT kits are Class IIb Medical Devices in EU certified by TÜV SÜD Product Services (Notified Body N°0123) REGENLAB, REGENKIT, REGENACR, PRP, A-PRP are registered trademarks of RegenLab SA in Europe, United States and other countries.
- U.S. patent US8529957 and Patents Pending, including EP2073862 and US2013010857